Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · IEX Real-Time Price · USD
14.98
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market closed

DAWN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Net Income
-208.94-188.92-142.18-170.64-40.51-12.63
Depreciation & Amortization
0.410.380.530.20.160
Share-Based Compensation
42.5439.3427.2413.320.530.11
Other Operating Activities
-4.612.344.53108.5826.3412.36
Operating Cash Flow
-170.6-146.85-109.87-48.54-13.49-4.52
Capital Expenditures
-0.2-0.22-0.030-0.090
Acquisitions
-3-30-800
Change in Investments
232.06131.6-255.05000
Investing Cash Flow
228.86128.38-255.07-8-0.090
Share Issuance / Repurchase
162.66162.66162.25167.3600
Debt Issued / Paid
000001
Other Financing Activities
0.21.343.65129.7629.9829.91
Financing Cash Flow
162.86164165.9297.1229.9830.91
Net Cash Flow
221.12145.52-199.05240.5816.426.39
Free Cash Flow
-170.8-147.08-109.9-48.54-13.58-4.52
Free Cash Flow Per Share
-1.97-1.84-1.68-1.31-2.46-0.76
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).